Featured Research

from universities, journals, and other organizations

Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids

Date:
August 9, 2012
Source:
American Roentgen Ray Society
Summary:
Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice –- hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile.

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice -hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can replace hysterectomy, which leaves women infertile.

The study, conducted at the Yonsei University College of Medicine in Seoul South Korea, included 40 women with 10 cm or larger uterine fibroids. Twelve of the women received gonadotropin-releasing hormone (GnRH) agonists to shrink their fibroids before undergoing uterine artery embolization, said Man Deuk Kim, MD, PhD, lead author of the study. The remaining 28 patients underwent uterine artery embolization alone.

There has been disagreement over offering uterine artery embolization to women with fibroids larger than 10 cm in diameter because of concerns about an increased risk of infection or sepsis, said Dr. Kim. "Our study found that by adding GnRH agonists as part of treatment, the large fibroids shrunk by about 36% on average and complications were reduced," he said. Major complications requiring hospitalization for more than 48 hours were not seen in the group that had both GnRH agonists and uterine artery embolization, while four patients from the group that were treated with uterine embolization alone suffered complications that required 48 or more hours of hospitalization, Dr. Kim noted.

GnRH agonist treatment does tend to make the uterine arteries smaller and more prone to temporary, sudden narrowing, said Dr. Kim. "However, our study showed adding GnRH to treatment did not prevent uterine artery embolization in patients with large fibroids," he said.

All patients treated with GnRH agonists and uterine artery embolization had successful procedures with follow-up of patients showing complete necrosis of the fibroids. Twelve patients treated with uterine artery embolization had successful procedures, said Dr. Kim.

"When patients who have large fibroids greater than 10 cm come to me seeking an alternative to surgery, I counsel them to consider GnRH agonists plus uterine artery embolization as a treatment option. Interventional radiologists may be unfamiliar with prescribing GnRH, but our study encourages them to consider GnRH as a pretreatment for patients with large fibroids who want to avoid surgery."

The study was published in the August issue of the American Journal of Roentgenology.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. M. D. Kim, M. Lee, M. S. Lee, S. I. Park, J. Y. WonQ, D. Y. Lee, K. H. Lee. Uterine Artery Embolization of Large Fibroids: Comparative Study of Procedure With and Without Pretreatment Gonadotropin-Releasing Hormone Agonists. American Journal of Roentgenology, 2012; 199 (2): 441 DOI: 10.2214/AJR.11.7220

Cite This Page:

American Roentgen Ray Society. "Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids." ScienceDaily. ScienceDaily, 9 August 2012. <www.sciencedaily.com/releases/2012/08/120809133849.htm>.
American Roentgen Ray Society. (2012, August 9). Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2012/08/120809133849.htm
American Roentgen Ray Society. "Hormone acting drugs and uterine artery embolization offers nonsurgical treatment for uterine fibroids." ScienceDaily. www.sciencedaily.com/releases/2012/08/120809133849.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins